RedHill Biopharma Adjourns Shareholder Meeting Due to Lack of Quorum
Ticker: RDHL · Form: 6-K · Filed: May 5, 2025 · CIK: 1553846
| Field | Detail |
|---|---|
| Company | Redhill Biopharma Ltd. (RDHL) |
| Form Type | 6-K |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: meeting-adjournment, corporate-governance, shareholder-meeting
Related Tickers: RHBP
TL;DR
RHBP meeting pushed to May 26th - no quorum today.
AI Summary
RedHill Biopharma Ltd. announced the adjournment of its Annual General Meeting of Shareholders, originally scheduled for May 5, 2025, due to a lack of legal quorum. The meeting has been postponed to May 26, 2025, at 3:00 p.m. Israel time, and will be held at the Company's offices in Tel-Aviv, Israel.
Why It Matters
Failure to achieve a quorum can delay important corporate decisions and governance processes, potentially impacting the company's strategic direction and shareholder engagement.
Risk Assessment
Risk Level: low — This filing is a procedural announcement regarding a meeting adjournment and does not contain significant financial or operational news.
Key Players & Entities
- RedHill Biopharma Ltd. (company) — Registrant
- May 5, 2025 (date) — Original meeting date
- May 26, 2025 (date) — New meeting date
- 21 Ha'arba'a Street, Tel-Aviv, Israel (location) — Company address and meeting location
FAQ
Why was the Annual General Meeting of Shareholders adjourned?
The meeting was adjourned due to a lack of the required legal quorum.
When has the Annual General Meeting of Shareholders been rescheduled to?
The meeting has been postponed to May 26, 2025.
What time will the rescheduled meeting take place?
The meeting will take place at 3:00 p.m. Israel time.
Where will the rescheduled meeting be held?
The meeting will be held at the Company's offices at 21 Ha'arba'a Street, Tel-Aviv, Israel.
What is the Commission File Number for RedHill Biopharma Ltd.'s 6-K filing?
The Commission File Number is 001-35773.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 5, 2025 regarding RedHill Biopharma Ltd. (RDHL).